New! Learn more about the all new DeepDyve personalized home page where you can quickly skim your favorite journals all from one place

Drug Metabolism and Disposition Volume 32 Issue 2

2013
- Volume 41
  - Issue 2 (Feb)
  - Issue 1 (Jan)
2012
- Volume 40
2011
- Volume 39
2010
- Volume 38
2009
- Volume 37
2008
- Volume 36
2007
- Volume 35
2006
- Volume 34
2005
- Volume 33
2004
- Volume 32
2003
- Volume 31
2002
- Volume 30
2001
- Volume 29
2000
- Volume 28
1999
- Volume 27
1998
- Volume 26
1997
- Volume 25

Bookmark
More Like This hN1vgMdUef Preview Only

CORRECTION TO “TWO NEW POLYMORPHISMS OF THE FMO3 GENE IN CAUCASIAN AND AFRICAN-AMERICAN POPULATIONS: COMPARATIVE GENETIC AND FUNCTIONAL STUDIES”

Follow Drug Metabolism and Disposition , Volume 32 (2): 280 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004
Bookmark
More Like This 4rzhNqcuYX Preview Only

EFFECT OF RECOMBINANT INTERLEUKIN-2 PRETREATMENT ON ORAL AND INTRAVENOUS DIGOXIN PHARMACOKINETICS AND P-GLYCOPROTEIN ACTIVITY IN MICE

Castagne, Vincent; Bonhomme-Faivre, Laurence; Urien, Saik; Reguiga, Makram Ben; Soursac, Mireille; Gimenez, Francois; Farinotti, Robert

Follow Drug Metabolism and Disposition , Volume 32 (2): 168 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004
Bookmark
More Like This QiAaQKJ18N Preview Only

POLYMORPHIC EXPRESSION OF CYP1A2 LEADING TO INTERINDIVIDUAL VARIABILITY IN METABOLISM OF A NOVEL BENZODIAZEPINE RECEPTOR PARTIAL INVERSE AGONIST IN DOGS

Mise, Masashi; Yadera, Seiji; Matsuda, Michiaki; Hashizume, Takanori; Matsumoto, Satoshi; Terauchi, Yoshiaki; Fujii, Toshihiko

Follow Drug Metabolism and Disposition , Volume 32 (2): 240 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004
Bookmark
More Like This kaomgOggpB Preview Only

INVOLVEMENT OF HUMAN HEPATIC UGT1A1, UGT2B4, AND UGT2B7 IN THE GLUCURONIDATION OF CARVEDILOL

Ohno, Akiko; Saito, Yoshiro; Hanioka, Nobumitsu; Jinno, Hideto; Saeki, Mayumi; Ando, Masanori; Ozawa, Shogo; Sawada, Jun-ichi

Follow Drug Metabolism and Disposition , Volume 32 (2): 235 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004
Bookmark
More Like This KTFyVLgUYb Preview Only

METABOLISM OF 8-PRENYLNARINGENIN, A POTENT PHYTOESTROGEN FROM HOPS (HUMULUS LUPULUS), BY HUMAN LIVER MICROSOMES

Nikolic, Dejan; Li, Yongmei; Chadwick, Lucas R.; Grubjesic, Simonida; Schwab, Pia; Metz, Peter; van Breemen, Richard B.

Follow Drug Metabolism and Disposition , Volume 32 (2): 272 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004
Bookmark
More Like This Ds0M3zKqN2 Preview Only

IDENTIFICATION OF A HYDROXYLAMINE GLUCURONIDE METABOLITE OF AN ORAL HYPOGLYCEMIC AGENT

Miller, Randall R.; Doss, George A.; Stearns, Ralph A.

Follow Drug Metabolism and Disposition , Volume 32 (2): 178 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004
Bookmark
More Like This qcwoSu3Hmi Preview Only

DEVELOPMENT OF AN IN VIVO PRECLINICAL SCREEN MODEL TO ESTIMATE ABSORPTION AND FIRST-PASS HEPATIC EXTRACTION OF XENOBIOTICS. II. USE OF KETOCONAZOLE TO IDENTIFY P-GLYCOPROTEIN/CYP3A-LIMITED BIOAVAILABILITY IN THE MONKEY

Ward, Keith W.; Stelman, Gary J.; Morgan, Jayme A.; Zeigler, Kelli S.; Azzarano, Leonard M.; Kehler, Jonathan R.; McSurdy-Freed, Jeanelle E.; Proksch, Joel W.; Smith, Brian R.

Follow Drug Metabolism and Disposition , Volume 32 (2): 172 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004
Bookmark
More Like This ltI7MA2jZO Preview Only

BIOTRANSFORMATION OF FUCOXANTHINOL INTO AMAROUCIAXANTHIN A IN MICE AND HEPG2 CELLS: FORMATION AND CYTOTOXICITY OF FUCOXANTHIN METABOLITES

Asai, Akira; Sugawara, Tatsuya; Ono, Hiroshi; Nagao, Akihiko

Follow Drug Metabolism and Disposition , Volume 32 (2): 205 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004
Bookmark
More Like This mK4qXXROqI Preview Only

PREDICTION OF CYTOCHROME P450 3A INHIBITION BY VERAPAMIL ENANTIOMERS AND THEIR METABOLITES

Wang, Ying-Hong; Jones, David R.; Hall, Stephen D.

Follow Drug Metabolism and Disposition , Volume 32 (2): 259 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004
Bookmark
More Like This 0Uhisnfmmm Preview Only

STEREOSELECTIVE PHARMACOKINETICS OF FLUOXETINE AND NORFLUOXETINE ENANTIOMERS IN PREGNANT SHEEP

Kim, John; Riggs, K. Wayne; Rurak, Dan W.

Follow Drug Metabolism and Disposition , Volume 32 (2): 212 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004

Drug Metabolism and Disposition Volume 32 Issue 2

CORRECTION TO “TWO NEW POLYMORPHISMS OF THE FMO3 GENE IN CAUCASIAN AND AFRICAN-AMERICAN POPULATIONS: COMPARATIVE GENETIC AND FUNCTIONAL STUDIES”

Follow Drug Metabolism and Disposition , Volume 32 (2): 280 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004

EFFECT OF RECOMBINANT INTERLEUKIN-2 PRETREATMENT ON ORAL AND INTRAVENOUS DIGOXIN PHARMACOKINETICS AND P-GLYCOPROTEIN ACTIVITY IN MICE

Castagne, Vincent; Bonhomme-Faivre, Laurence; Urien, Saik; Reguiga, Makram Ben; Soursac, Mireille; Gimenez, Francois; Farinotti, Robert

Follow Drug Metabolism and Disposition , Volume 32 (2): 168 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004

POLYMORPHIC EXPRESSION OF CYP1A2 LEADING TO INTERINDIVIDUAL VARIABILITY IN METABOLISM OF A NOVEL BENZODIAZEPINE RECEPTOR PARTIAL INVERSE AGONIST IN DOGS

Mise, Masashi; Yadera, Seiji; Matsuda, Michiaki; Hashizume, Takanori; Matsumoto, Satoshi; Terauchi, Yoshiaki; Fujii, Toshihiko

Follow Drug Metabolism and Disposition , Volume 32 (2): 240 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004

INVOLVEMENT OF HUMAN HEPATIC UGT1A1, UGT2B4, AND UGT2B7 IN THE GLUCURONIDATION OF CARVEDILOL

Ohno, Akiko; Saito, Yoshiro; Hanioka, Nobumitsu; Jinno, Hideto; Saeki, Mayumi; Ando, Masanori; Ozawa, Shogo; Sawada, Jun-ichi

Follow Drug Metabolism and Disposition , Volume 32 (2): 235 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004

METABOLISM OF 8-PRENYLNARINGENIN, A POTENT PHYTOESTROGEN FROM HOPS (HUMULUS LUPULUS), BY HUMAN LIVER MICROSOMES

Nikolic, Dejan; Li, Yongmei; Chadwick, Lucas R.; Grubjesic, Simonida; Schwab, Pia; Metz, Peter; van Breemen, Richard B.

Follow Drug Metabolism and Disposition , Volume 32 (2): 272 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004

IDENTIFICATION OF A HYDROXYLAMINE GLUCURONIDE METABOLITE OF AN ORAL HYPOGLYCEMIC AGENT

Miller, Randall R.; Doss, George A.; Stearns, Ralph A.

Follow Drug Metabolism and Disposition , Volume 32 (2): 178 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004

DEVELOPMENT OF AN IN VIVO PRECLINICAL SCREEN MODEL TO ESTIMATE ABSORPTION AND FIRST-PASS HEPATIC EXTRACTION OF XENOBIOTICS. II. USE OF KETOCONAZOLE TO IDENTIFY P-GLYCOPROTEIN/CYP3A-LIMITED BIOAVAILABILITY IN THE MONKEY

Ward, Keith W.; Stelman, Gary J.; Morgan, Jayme A.; Zeigler, Kelli S.; Azzarano, Leonard M.; Kehler, Jonathan R.; McSurdy-Freed, Jeanelle E.; Proksch, Joel W.; Smith, Brian R.

Follow Drug Metabolism and Disposition , Volume 32 (2): 172 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004

BIOTRANSFORMATION OF FUCOXANTHINOL INTO AMAROUCIAXANTHIN A IN MICE AND HEPG2 CELLS: FORMATION AND CYTOTOXICITY OF FUCOXANTHIN METABOLITES

Asai, Akira; Sugawara, Tatsuya; Ono, Hiroshi; Nagao, Akihiko

Follow Drug Metabolism and Disposition , Volume 32 (2): 205 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004

PREDICTION OF CYTOCHROME P450 3A INHIBITION BY VERAPAMIL ENANTIOMERS AND THEIR METABOLITES

Wang, Ying-Hong; Jones, David R.; Hall, Stephen D.

Follow Drug Metabolism and Disposition , Volume 32 (2): 259 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004

STEREOSELECTIVE PHARMACOKINETICS OF FLUOXETINE AND NORFLUOXETINE ENANTIOMERS IN PREGNANT SHEEP

Kim, John; Riggs, K. Wayne; Rurak, Dan W.

Follow Drug Metabolism and Disposition , Volume 32 (2): 212 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004

Advanced Filters:

Specific Data Sources:

Drug Metabolism and Disposition Volume 32 Issue 2

1 - 10 of 17 articles

Follow Drug Metabolism and Disposition , Volume 32 (2): 280 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004

Castagne, Vincent; Bonhomme-Faivre, Laurence; Urien, Saik; Reguiga, Makram Ben; Soursac, Mireille; Gimenez, Francois; Farinotti, Robert

Follow Drug Metabolism and Disposition , Volume 32 (2): 168 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004

Mise, Masashi; Yadera, Seiji; Matsuda, Michiaki; Hashizume, Takanori; Matsumoto, Satoshi; Terauchi, Yoshiaki; Fujii, Toshihiko

Follow Drug Metabolism and Disposition , Volume 32 (2): 240 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004

Ohno, Akiko; Saito, Yoshiro; Hanioka, Nobumitsu; Jinno, Hideto; Saeki, Mayumi; Ando, Masanori; Ozawa, Shogo; Sawada, Jun-ichi

Follow Drug Metabolism and Disposition , Volume 32 (2): 235 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004

Nikolic, Dejan; Li, Yongmei; Chadwick, Lucas R.; Grubjesic, Simonida; Schwab, Pia; Metz, Peter; van Breemen, Richard B.

Follow Drug Metabolism and Disposition , Volume 32 (2): 272 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004

Miller, Randall R.; Doss, George A.; Stearns, Ralph A.

Follow Drug Metabolism and Disposition , Volume 32 (2): 178 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004

Ward, Keith W.; Stelman, Gary J.; Morgan, Jayme A.; Zeigler, Kelli S.; Azzarano, Leonard M.; Kehler, Jonathan R.; McSurdy-Freed, Jeanelle E.; Proksch, Joel W.; Smith, Brian R.

Follow Drug Metabolism and Disposition , Volume 32 (2): 172 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004

Asai, Akira; Sugawara, Tatsuya; Ono, Hiroshi; Nagao, Akihiko

Follow Drug Metabolism and Disposition , Volume 32 (2): 205 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004

Wang, Ying-Hong; Jones, David R.; Hall, Stephen D.

Follow Drug Metabolism and Disposition , Volume 32 (2): 259 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004

Kim, John; Riggs, K. Wayne; Rurak, Dan W.

Follow Drug Metabolism and Disposition , Volume 32 (2): 212 Am. Soc for Pharma & Experimental Therapeutics – Feb 1, 2004